Glycopyrronium/Formoterol: A Review in COPD

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD

(2019) François Maltais et al.   ADVANCES IN THERAPY

Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology

(2018) Glyn Taylor et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology

(2018) Gary T. Ferguson et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Randomized study of the effects of Aerochamber Plus ® Flow-Vu ® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease

(2018) Faisal Fakih et al.   RESPIRATORY MEDICINE

Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD

(2018) Gary T Ferguson et al.   International Journal of Chronic Obstructive Pulmonary Disease

Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects

(2018) Colin Reisner et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

(2018) Wilfried De Backer et al.   International Journal of Chronic Obstructive Pulmonary Disease

Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA

(2018) Brian J Lipworth et al.   International Journal of Chronic Obstructive Pulmonary Disease

An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease

(2018) Krishna Pudi et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

EFFICACY AND SAFETY OF GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE METERED DOSE INHALER (GFF MDI) DELIVERED USING CO-SUSPENSION DELIVERY TECHNOLOGY IN CHINESE PATIENTS WITH COPD

(2018)   RESPIROLOGY

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis

(2018) Mohamed Ismail Abdul Aziz et al.   International Journal of Chronic Obstructive Pulmonary Disease

Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease

(2017) Nicola A. Hanania et al.   RESPIRATORY MEDICINE

A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD

(2016) Donald P. Tashkin et al.   RESPIRATORY MEDICINE

Inhaled Glycopyrronium Bromide: A Review of its Use in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease

(2013) Natalie J. Carter   DRUGS

Budesonide/Formoterol Turbuhaler®

(2012) Lesley J. Scott   DRUGS

Cosuspensions of Microcrystals and Engineered Microparticles for Uniform and Efficient Delivery of Respiratory Therapeutics from Pressurized Metered Dose Inhalers

(2012) Reinhard Vehring et al.   LANGMUIR